Search for: "AMGEN V ITC"
Results 1 - 20
of 48
Sorted by Relevance
|
Sort by Date
8 Apr 2010, 4:41 pm
On April 6, 2010, the ITC issued a notice granting Amgen, Inc. [read post]
4 May 2009, 8:10 pm
By Andrew Williams -- Last year, a panel of the Federal Circuit affirmed the International Trade Commission's (ITC's) grant of summary judgment against Amgen in its attempts to block importation of Roche's Micera ® peglylated erythropoietin product. [read post]
19 Mar 2008, 12:14 pm
Amgen v. [read post]
7 May 2009, 2:19 pm
Amgen v. [read post]
20 Mar 2008, 9:56 pm
Federal Circuit Gives Amgen a Mixed Decision on Its ITC Complaint against Roche's Mircera ® By Kevin E. [read post]
21 Mar 2008, 1:04 pm
Amgen v. [read post]
19 Mar 2008, 3:17 pm
The ITC's jurisdiction under § 1337, according to the court, is broad, and it therefore erred in holding that it lacked jurisdiction absent an actual sale or contract for sale of the imported product.More detail of Amgen, Inc. v. [read post]
19 Aug 2017, 8:06 pm
Amgen from an ANDA litigator’s point of view • The FDA Final MMA Rule • Novartis v. [read post]
28 Jan 2019, 11:22 pm
Ct. 1664, 2017; Amgen v Sandoz, 877 F.3d 1315, Fed. [read post]
13 Oct 2016, 6:50 am
Apple) ITC Jurisdiction: DBN Holding, Inc. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to… [read post]
12 Apr 2010, 11:10 pm
Amgen, Inc., 475 F.3d 1256, 1263 (Fed. [read post]
11 Mar 2010, 12:28 pm
Ajinomoto v. [read post]
6 Apr 2017, 1:35 pm
See Medicines Co. v. [read post]
6 Sep 2010, 12:42 am
Kirin Amgen Inc. v Lietuvos Respublikos valstybinis patent? [read post]
24 Nov 2010, 8:22 am
Patent No. 7,511,043 owned by Amgen and entitled FXR MODULATIONS. [read post]
24 Nov 2010, 8:22 am
Patent No. 7,511,043 owned by Amgen and entitled FXR MODULATIONS. [read post]
1 Mar 2023, 6:09 am
How could the ITC reach such a result? [read post]
4 Mar 2016, 12:25 pm
Amgen (BCPIA’s inherent six-month delay following commercial marketing notice); Hemopet v. [read post]
15 Apr 2010, 4:27 am
(Spicy IP) Argentina: Argentina’s scientific data laws and TRIPs compliance (IP tango) Chile: Secretary General of International Seed Federation visits Chile, pressures nation to sign UPOV 91 (IP tango) EU: AHP Manufacturing BV v Bureau voor de Industriële Eigendom analysis now in print (The SPC Blog) Hungary: Metropolitan Appeal Court: Preliminary injunction refused concerning combination patent (EPLAW) Hungary: Metropolitan Appeal Court of Budapest upholds decision of… [read post]
